Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by the degeneration of dopaminergic neurons of the substantia nigra and the accumulation of protein aggregates, called Lewy bodies, where the most abundant is alpha‐synuclein (α‐SYN). Mutations of the gene that codes for α‐SYN (SNCA), such as the A53T mutation, and duplications of the gene generate cases of PD with autosomal dominant inheritance. As a result of the association of inflammation with the neurodegeneration of PD, we analyzed whether overexpression of wild‐type α‐SYN (α‐SYN WT) or mutated α‐SYN (α‐SYN A53T) are involved in the neuronal dopaminergic loss and inflammation process, along with the role of the chemokine fractalkine (CX3CL1) and its receptor (CX3CR1). We generated in vivo murine models overexpressing human α‐SYN WT or α‐SYN A53T in wild type (Cx3cr1+/+) or deficient (Cx3cr1–/–) mice for CX3CR1 using unilateral intracerebral injection of adeno‐associated viral vectors. No changes in CX3CL1 levels were observed by immunofluorescence or analysis by qRT‐PCR in this model. Interestingly, the expression α‐SYN WT induced dopaminergic neuronal death to a similar degree in both genotypes. However, the expression of α‐SYN A53T produced an exacerbated neurodegeneration, enhanced in the Cx3cr1–/– mice. This neurodegeneration was accompanied by an increase in neuroinflammation and microgliosis as well as the production of pro‐inflammatory markers, which were exacerbated in Cx3cr1–/– mice overexpressing α‐SYN A53T. Furthermore, we observed that in primary microglia CX3CR1 was a critical factor in the modulation of microglial dynamics in response to α‐SYN WT or α‐SYN A53T. Altogether, our study reveals that CX3CR1 plays an essential role in neuroinflammation induced by α‐SYN A53T.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · cited 1×
“It binds to its receptor CX3CR1 located in the microglia at the CNS, acting as a bridge of connection between neurons and microglia (Bisht et al., 2016; Ransohoff, 2016).”
BackgroundMicroglia in physiology and disease
Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 1×
“This indicates that microglial cells can be activated by a-SYN (Hoenen et al., 2016; Zhang et al., 2005).”
BackgroundDark microglia: A new phenotype predominantly associated with pathological states
Bisht, K., Sharma, K. P., Lecours, C., Gabriela Sánchez, M., El Hajj, H., Milior, G., Olmos‐Alonso, A., Gómez‐Nicola, D., Luheshi, G., Vallières, L., et al. (2016) · Glia · doi:10.1002/glia.22966 · Cited by 421 · cited 1×
“The elevated body swing test is a simple and easy behavioral test that only requires handling the animal by its tail and recording the direction of swings made by the animal for a certain period (Bentea et al., 2015; Borlongan & Sanberg, 1995).”
BackgroundTunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C. (2016) · The EMBO Journal · doi:10.15252/embj.201593411 · Cited by 414
Carson, M. J., Cameron Thrash, J., & Walter, B. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.004 · Cited by 299
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A., & Perry, V. H. (2002) · Glia · doi:10.1002/glia.10037 · Cited by 252
Research works printed but not linked: 25
- 10.3389/fnbeh.2015.00068 · DOI · Paper page
- 10.1523/JNEUROSCI.15-07-05372.1995 · DOI · Paper page
- 10.1016/j.nbd.2015.03.003 · DOI · Paper page
- 10.1074/jbc.M113.540633 · DOI · Paper page
- 10.1016/j.bbi.2013.02.005 · DOI · Paper page
- 10.1093/brain/awr149 · DOI · Paper page
- 10.3389/fnins.2015.00059 · DOI
- 10.1002/glia.21229 · DOI
- 10.1111/j.1365-2818.1987.tb02837.x · DOI · Paper page
- 10.1371/journal.pone.0162717 · DOI · Paper page
- 10.1089/gtmb.2011.0330 · DOI
- 10.1101/cshperspect.a008888 · DOI · Paper page
- 10.1371/journal.pone.0011464 · DOI
- 10.1186/1750-1326-7-S1-L21 · DOI
- Lastres‐Becker I., 2017, Role of the transcription factor Nrf2 in Parkinson's disease: New Insights, Journal of Alzheimers Disease and Parkinsonism, 7, 9
- 10.1089/ars.2015.6549 · DOI · Paper page
- 10.1093/brain/awt323 · DOI · Paper page
- 10.1093/hmg/dds143 · DOI · Paper page
- 10.1111/nyas.12805 · DOI · Paper page
- 10.1371/journal.pone.0096528 · DOI · Paper page
- Lopez‐Lopez A., 2017, Association of the CX3CR1‐V249I variant with neurofibrillary pathology progression in late‐onset Alzheimer's disease, Molecular Neurobiology
- 10.1038/mt.2014.175 · DOI · Paper page
- Pacheco C., 2012, An extracellular mechanism that can explain the neurotoxic effects of α‐synuclein aggregates in the brain, Frontiers in Physiology, 3
- 10.1371/journal.pone.0140566 · DOI · Paper page
- 10.1002/glia.20532 · DOI · Paper page
Cited by
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779
Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
Gómez-Benito, M., Granado, N., García-Sanz, P., Michel, A., Dumoulin, M., & Moratalla, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00356 · Cited by 437
Microglia and astrocyte dysfunction in parkinson's disease
Kam, T.-I., Hinkle, J. T., Dawson, T. M., & Dawson, V. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105028 · Cited by 389
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 379
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Wendimu, M. Y., & Hooks, S. B. (2022) · Cells · doi:10.3390/cells11132091 · Cited by 336
Metadata
- Authors
- Castro‐Sánchez, S., García‐Yagüe, Á. J., López‐Royo, T., Casarejos, M., Lanciego, J. L., & Lastres‐Becker, I.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2018-04-06
- Volume
- 66
- Issue
- 8
- Pages
- 1752-1762
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2795978601
- Cited by
- 89
- References
- 8
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Spanish Ministry of Economy and Competitiveness (SAF2016-76520-R, BFU2017-82407-R)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. https://app.cochat.ai/papers/10.1002/glia.23338
- The paper
- Castro‐Sánchez, S., García‐Yagüe, Á. J., López‐Royo, T., Casarejos, M., Lanciego, J. L., & Lastres‐Becker, I. (2018). Cx3cr1‐deficiency exacerbates alpha‐synuclein‐A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease. Glia. https://doi.org/10.1002/glia.23338
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.